Relationship Between Polycystic Ovary Syndrome and Early Menarche
DOI:
https://doi.org/10.36489/saudecoletiva.2025v15i97p16028-16039Keywords:
Polycystic Ovary Syndrome, Obesity, MenarcheAbstract
Objective: To investigate the association between early menarche and endocrine factors, focusing on obesity in women with Polycystic Ovary Syndrome (PCOS). Method: Observational study based on an online questionnaire applied to 198 women with PCOS. Data on menarche age, sleep schedule, and BMI were analyzed. Results: Menarche at age 12 was associated with a 2.17-fold increased risk of obesity. Women who slept after midnight had up to a 13.3-fold higher chance of grade II obesity. Conclusion: Sleep quality has a stronger influence on obesity risk in women with PCOS than age at menarche.
References
Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am. 2018;53(3):407–420. https://doi.org/10.1016/j.cnur.2018.04.008
Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284. https://doi.org/10.1038/nrendo.2018.24
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, et al. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci. 2022;23(2):583. https://doi.org/10.3390/ijms23020583
Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. https://doi.org/10.1016/j.metabol.2018.11.002
Hachul H, Polesel DN, Tock L, Carneiro G, Pereira AZ, Zanella MT, et al. Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism. Rev Assoc Med Bras (1992). 2019;65(3):375–383. https://doi.org/10.1590/1806-9282.65.3.375
Guan Q, Wang Z, Cao J, Dong Y, Chen Y. Mechanisms of melatonin in obesity: a review. Int J Mol Sci. 2022;23(1):218. https://doi.org/10.3390/ijms23010218
Manique MES, Soares LA, Lucion AB. Síndrome dos ovários policísticos: fisiopatologia e manifestações clínicas. J Bras Reprod Assist. 2022;26(1):63–70.
Soccol MCH, Machado D, Abegg MA. A influência da microbiota intestinal na síndrome dos ovários policísticos: revisão de literatura. Rev Bras Nutr Func. 2022;17(1):162–71.
Righi GM, Orso KG, Vieira AT, Costa-Casagrande TA. Microbiota intestinal, probióticos e síndrome dos ovários policísticos: revisão de literatura. Arch Health Invest. 2021;10(1):50–6.
Zimberg IZ, Damaso AR, Del Re M, Carneiro AM, de Sá Souza H, Tufik S, et al. Chronobiological aspects of obesity and the role of melatonin. Arq Bras Endocrinol Metabol. 2017;61(3):284–291.
Arik GN, Coskun E, Caglayan EK, Vural M, Kizilkale O. Effects of melatonin on ovarian morphology and oxidative stress in a rat model of polycystic ovary syndrome. Exp Ther Med. 2023;25(3):216. https://doi.org/10.3892/etm.2023.11825
Nascimento RP, Santos LM, Oliveira GJPL, Costa Júnior JG, Moura LB. Influência da melatonina na função ovariana em pacientes com síndrome dos ovários policísticos: revisão. Rev Bras Ginecol Obstet. 2022;44(2):187–93.
Thannickal A, Arora T, Wehrens SMT. Melatonin and obesity: current status and future perspectives. J Pineal Res. 2020;69(4):e12691. https://doi.org/10.1111/jpi.12691.








